Prices are updated after-hours

Health Technology Pharmaceuticals: generic

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVJF | $12.37 -24.22% 380

(0.0% 1d) (0.0% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (83.09% volume)
Earnings Calendar:
Market Cap: $ 14,739,472,016
http://www.teva.co.il
Sec Filling | Patents | n/a employees

(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

cancer infectious disease pain relief israel cardiovascular

add to watch list Paper trade email alert is off

Aspen Pharmacare Holdings Ltd / ADR

APNHF | $9.205 25.91% 100

Health Technology

(0.0% 1d) (0.0% 1m) (0.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-88.89% volume)
Earnings Calendar:
Market Cap: $ 4,107,752,716
http://www.aspenpharma.com
Sec Filling | Patents | n/a employees

(ZA) Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the following segments: Sterile Focused Brands, Anaesthetics Brands, and Thrombosis Brands. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.

brands

add to watch list Paper trade email alert is off

Jaguar Health, Inc.

JAGX | $0.1772 7.46% 6.94% 68M

Health Technology

(0.0% 1d) (125.3% 1m) (-69.3% 1y) (0.0% 2d) (12.5% 3d) (51.5% 7d) (-48.25% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 48,945,521
http://www.jaguar.health
Sec Filling | Patents | 29 employees

(US) Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

diarrhea hiv gastrointestinal animals

add to watch list Paper trade email alert is off

Abeona Therapeutics Inc.

ABEO | $7.55 -4.79% -5.03% 250K

Health Technology

(0.0% 1d) (0.0% 1m) (143.7% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (12.54% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 206,530,529
http://www.abeonatherapeutics.com
Sec Filling | Patents | 88 employees

(US) Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

skin gene therapies

add to watch list Paper trade email alert is off

Cocrystal Pharma, Inc.

COCP | $1.43 -1.39% 5.1K

Health Technology

(0.0% 1d) (-1.3% 1m) (-36.7% 1y) (0.0% 2d) (0.0% 3d) (6.5% 7d) (-73.53% volume)
Earnings Calendar: 2024-03-27
Market Cap: $ 14,548,520
http://www.cocrystalpharma.com
Sec Filling | Patents | 11 employees

(US) Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.

antiviral influenza hepatitis norovirus drug discovery injection

add to watch list Paper trade email alert is off

Dr. Reddy's Laboratories Ltd

RDY | $70.91 -0.56% 0.0% 97K

Health Technology

(0.0% 1d) (-2.1% 1m) (19.5% 1y) (0.0% 2d) (0.0% 3d) (0.3% 7d) (-5.04% volume)
Earnings Calendar:
Market Cap: $ 11,833,314,654
http://www.drreddys.com
Sec Filling | Patents | 21650 employees

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API or bulk drugs, which are principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research, development, and manufacture of differentiated formulations and new chemical entities. The Others segment includes the operations of the wholly-owned subsidiary of the company, Aurigene Discovery Technologies Limited, a discovery stage biotechnology company developing novel and best-in-class therapies in the fields of oncology and inflammation and which works with pharmaceutical and biotechnology companies in early-stage collaborations, brining drug candidates for pre-clinical development. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

glass pest brands

add to watch list Paper trade email alert is off

Lifevantage Corporation

LFVN | News | $6.65 0.76% 0.75% 23K

Health Technology

(0.0% 1d) (-5.0% 1m) (90.5% 1y) (0.0% 2d) (0.2% 3d) (15.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-05-04
Market Cap: $ 85,575,272
http://www.lifevantage.com
Sec Filling | Patents | 247 employees

(US) LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

add to watch list Paper trade email alert is off

Taro Pharmaceutical Industries Ltd.

TARO | $42.19 -0.12% 0.0% 31K

Health Technology

(0.0% 1d) (-0.2% 1m) (66.7% 1y) (0.0% 2d) (0.0% 3d) (0.3% 7d) (-27.74% volume)
Earnings Calendar:
Market Cap: $ 1,585,695,582
http://www.taro.com
Sec Filling | Patents | 1464 employees

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

cardiovascular israel neuropsychiatric

add to watch list Paper trade email alert is off

Teva Pharmaceutical Industries Limited

TEVA | $12.78 -3.03% -0.24% 9M

Health Technology

(0.0% 1d) (-2.2% 1m) (57.8% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (-18.75% volume)
Earnings Calendar:
Market Cap: $ 14,326,282,834
http://www.teva.co.il
Sec Filling | Patents | 40039 employees

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

cardiovascular cancer infectious disease israel pain relief

add to watch list Paper trade email alert is off

TherapeuticsMD, Inc.

TXMD | $1.98 4.76% 4.55% 5.7K

Health Technology

(0.0% 1d) (-19.6% 1m) (-48.8% 1y) (0.0% 2d) (0.0% 3d) (-3.1% 7d) (-36.44% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 22,834,237
http://www.therapeuticsmd.com
Sec Filling | Patents | 348 employees

(United States) TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

hormone women brands

Drugs

ANNOVERA (segesterone acetate and ethinyl estradiol)
Bijuva (estradiol and progesterone)
IMVEXXY (estradiol)

add to watch list Paper trade email alert is off

Zoetis Inc.

ZTS | News | $153.11 1.05% 0.48% 4.8M

Health Technology

(0.0% 1d) (-11.5% 1m) (-13.2% 1y) (0.0% 2d) (-0.4% 3d) (1.1% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 70,026,302,787
http://www.zoetis.com
Sec Filling | Patents | 10600 employees

(US) Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

vaccine animals veterinarians seeds genetic diagnostics

add to watch list Paper trade email alert is off

China Pharma Holdings, Inc.

CPHI | $0.32 -4.82% 5.63% 350K

Health Technology

(0.0% 1d) (-7.7% 1m) (-9.2% 1y) (0.0% 2d) (0.0% 3d) (-6.4% 7d) (3599.07% volume)
Earnings Calendar:
Market Cap: $ 4,741,397
http://www.chinapharmaholdings.com
Sec Filling | Patents | 242 employees

(China (Mainland)) China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. It caters people with cardiovascular, central nervous system, infectious, and digestive diseases. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.

cardiovascular china nervous system

add to watch list Paper trade email alert is off